Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
The ProstACT Phase 3 trial for advanced prostate cancer has begun its treatment phase with the first patient dosed, showing no safety issues so far.
The ProstACT global Phase 3 trial has begun its randomized treatment expansion phase with the first patient dosed, building on prior results.
The trial, evaluating an investigational treatment for advanced prostate cancer across multiple countries, plans to release Part 1 results in the coming months.
Initial safety data show no adverse events, and the trial is progressing on schedule with full regulatory and ethical compliance.
Results will be reviewed by an independent committee before public release.
11 Articles
El ensayo de Fase 3 ProstACT para el cáncer de próstata avanzado ha comenzado su fase de tratamiento con la primera dosis administrada al paciente, sin mostrar problemas de seguridad hasta el momento.